Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early-Stage Hepatocellular Carcinoma.

Aliment Pharmacol Ther · 2026 · PMC12807343 · PMID 40875577

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The 13‐metabolite signature remained associated with overall recurrence (aHR 2.5, 95% CI 1.1–6.0), whereas associations with early and late recurrence did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.